Challenges you may be facing
With a changing landscape, evolving healthcare, and the increasing complexity of multiple touch points, medical device companies are facing many challenges today. The confluence of these factors is creating the “perfect storm” for them.
Given some of the recent trends, the current models of delivering healthcare may not be sustainable. CEOs are looking at emerging opportunities to achieve both top and bottom line mandates by continuing to grow market share, introduce product innovation, drive incremental revenues, and maximize profitability.
The collision of Medtech and healthcare IT provides a unique opportunity for medical device companies to partner with physicians, patients, providers, hospital systems, and governments and other regulatory bodies that will lead to some interesting business model transformation. The focus is shifting from products to services and a “fee-for-service” model to one that rewards quality and outcomes. CIO’s will play a very critical role in driving innovation and transformation, improving operations and process efficiencies, optimizing costs, and driving business value to fund growth in the future.
What we can do for you
HCL is working with some of the top medical device companies across their value chains, and successfully delivering projects across R&D, engineering, manufacturing, sales and marketing and enterprise IT. By working with leading payers, providers, and pharmaceutical /CROs across the globe we’ve been able to drive successful transformation initiatives that are focussed on improving the alignment between business and IT.
Working with us gives you the following advantages:
Improve time to market and cost of new product development introduction by 20 - 30% through strategic product engineering partnerships
Leverage our global delivery model to implement enterprise applications such as ERP, PLM, MES, CRM, and more from product vendors such as SAP, Oracle, and Salesforce.com
Improve working capital efficiency and maximize asset utilization by 30-40% through accelerated Integration benefits and implementing an “Enterprise of the Future” strategy
Co-invest in Engineering / Mobility / Technology Labs that are ISO 13485 certified to drive experiential innovation and exploiting SMAC capabilities
Reinvest capital /fund change the business (CTB) initiatives by reducing run the business (RTB) spend by 20-30% (committed) savings through our ALT ASM™ proposition along with creating process transparency and driving measurable improvements to business KPIs
Develop a “digital ready“ technology platform to reduce “IT intensity” and improve “IT agility” by accelerating the build, implementation and support of current and future business capabilities
Drive differentiation by enabling, partnering and integrating across patient, provider and payer ecosystems to improve overall mind-share of your products
For more information, write to us at: firstname.lastname@example.org
M2M Communications in Medical Devices